215 related articles for article (PubMed ID: 16931569)
21. Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection.
Cross TJ; Calvaruso V; Maimone S; Carey I; Chang TP; Pleguezuelo M; Manousou P; Quaglia A; Grillo F; Dhillon AP; Dusheiko GM; Burroughs AK; Harrison PM
J Viral Hepat; 2010 Aug; 17(8):546-54. PubMed ID: 19874477
[TBL] [Abstract][Full Text] [Related]
22. Screening for liver fibrosis by using FibroScan(®) and FibroTest in patients with diabetes.
de Lédinghen V; Vergniol J; Gonzalez C; Foucher J; Maury E; Chemineau L; Villars S; Gin H; Rigalleau V
Dig Liver Dis; 2012 May; 44(5):413-8. PubMed ID: 22285146
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest).
Poynard T; Lebray P; Ingiliz P; Varaut A; Varsat B; Ngo Y; Norha P; Munteanu M; Drane F; Messous D; Bismut FI; Carrau JP; Massard J; Ratziu V; Giordanella JP
BMC Gastroenterol; 2010 Apr; 10():40. PubMed ID: 20412588
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study.
Köksal İ; Yılmaz G; Parlak M; Demirdal T; Kınıklı S; Candan M; Kaya A; Akhan S; Aydoğdu Ö; Turgut H; Gürbüz Y; Dağlı Ö; Gökal AA; Güner R; Kuruüzüm Z; Tarakçı H; Beslen N; Erdoğan S; Özdener F; Study Group TCHC
Turk J Gastroenterol; 2018 Jul; 29(4):464-472. PubMed ID: 30249562
[TBL] [Abstract][Full Text] [Related]
25. FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B.
Zeremski M; Dimova RB; Benjamin S; Makeyeva J; Yantiss RK; Gambarin-Gelwan M; Talal AH
BMC Gastroenterol; 2014 Jul; 14():118. PubMed ID: 24990385
[TBL] [Abstract][Full Text] [Related]
26. Development and validation of a nomogram based on clinical factors and standard laboratory tests for prediction of clinically significant liver fibrosis in chronic hepatitis C virus infection.
Sagrini E; Ardoino I; Marano G; Gianstefani A; Orlandini A; Sebastiani G; Donati G; Cucchetti A; Pelosi G; Ferrari C; Alberti A; Biganzoli E; Piscaglia F; Bolondi L
Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1385-95. PubMed ID: 23839163
[TBL] [Abstract][Full Text] [Related]
27. FibroTest-ActiTest as a non-invasive marker of liver fibrosis.
Halfon P; Munteanu M; Poynard T
Gastroenterol Clin Biol; 2008 Sep; 32(6 Suppl 1):22-39. PubMed ID: 18973844
[TBL] [Abstract][Full Text] [Related]
28. Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers.
Vermehren J; Vermehren A; Mueller A; Carlebach A; Lutz T; Gute P; Knecht G; Sarrazin C; Friedrich-Rust M; Forestier N; Poynard T; Zeuzem S; Herrmann E; Hofmann WP
BMC Gastroenterol; 2012 Mar; 12():27. PubMed ID: 22453133
[TBL] [Abstract][Full Text] [Related]
29. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
Sebastiani G; Vario A; Guido M; Alberti A
J Viral Hepat; 2008 Mar; 15(3):212-8. PubMed ID: 18179453
[TBL] [Abstract][Full Text] [Related]
30. FibroTest and Fibroscan performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rate.
Poynard T; de Ledinghen V; Zarski JP; Stanciu C; Munteanu M; Vergniol J; France J; Trifan A; Moussalli J; Lebray P; Thabut D; Ratziu V
Clin Res Hepatol Gastroenterol; 2011 Nov; 35(11):720-30. PubMed ID: 21852224
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of acoustic radiation force impulse and fibrotest in liver fibrosis assessment after liver transplant.
Bignulin S; Falleti E; Cmet S; Cappello D; Cussigh A; Lenisa I; Dissegna D; Pugliese F; Vivarelli C; Fabris C; Fabris C; Toniutto P
Ann Hepatol; 2016; 15(2):200-6. PubMed ID: 26845597
[TBL] [Abstract][Full Text] [Related]
32. Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C.
Rosenthal-Allieri MA; Tran A; Halfon P; Imbert-Bismut F; Munteanu M; Messous D; Peritore ML; Poynard T; Bernard A
Gastroenterol Clin Biol; 2007 Oct; 31(10):815-21. PubMed ID: 18166859
[TBL] [Abstract][Full Text] [Related]
33. Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease.
Thiele M; Madsen BS; Hansen JF; Detlefsen S; Antonsen S; Krag A
Gastroenterology; 2018 Apr; 154(5):1369-1379. PubMed ID: 29317276
[TBL] [Abstract][Full Text] [Related]
34. Prospective evaluation of FibroTest®, FibroMeter®, and HepaScore® for staging liver fibrosis in chronic hepatitis B: comparison with hepatitis C.
Leroy V; Sturm N; Faure P; Trocme C; Marlu A; Hilleret MN; Morel F; Zarski JP
J Hepatol; 2014 Jul; 61(1):28-34. PubMed ID: 24631902
[TBL] [Abstract][Full Text] [Related]
35. Enhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for HIV.
Peters MG; Bacchetti P; Boylan R; French AL; Tien PC; Plankey MW; Glesby MJ; Augenbraun M; Golub ET; Karim R; Parkes J; Rosenberg W
AIDS; 2016 Mar; 30(5):723-9. PubMed ID: 26595542
[TBL] [Abstract][Full Text] [Related]
36. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.
Castéra L; Vergniol J; Foucher J; Le Bail B; Chanteloup E; Haaser M; Darriet M; Couzigou P; De Lédinghen V
Gastroenterology; 2005 Feb; 128(2):343-50. PubMed ID: 15685546
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus.
Berenguer J; Zamora FX; Aldámiz-Echevarría T; Von Wichmann MA; Crespo M; López-Aldeguer J; Carrero A; Montes M; Quereda C; Téllez MJ; Galindo MJ; Sanz J; Santos I; Guardiola JM; Barros C; Ortega E; Pulido F; Rubio R; Mallolas J; Tural C; Jusdado JJ; Pérez G; Díez C; Álvarez-Pellicer J; Esteban H; Bellón JM; González-García J;
Clin Infect Dis; 2015 Mar; 60(6):950-8. PubMed ID: 25422386
[TBL] [Abstract][Full Text] [Related]
38. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.
Adams LA; Bulsara M; Rossi E; DeBoer B; Speers D; George J; Kench J; Farrell G; McCaughan GW; Jeffrey GP
Clin Chem; 2005 Oct; 51(10):1867-73. PubMed ID: 16055434
[TBL] [Abstract][Full Text] [Related]
39. Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.
Schiavon LL; Narciso-Schiavon JL; Carvalho Filho RJ; Sampaio JP; Medina-Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
J Viral Hepat; 2008 Sep; 15(9):666-74. PubMed ID: 18482283
[TBL] [Abstract][Full Text] [Related]
40. [Serum markers of non-invasive fibrosis in chronic hepatitis C virus infection].
Halfon P; Bourlière M; Pénaranda G; Cacoub P
Rev Med Interne; 2006 Oct; 27(10):751-61. PubMed ID: 16815598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
